| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CASSAVA SCIENCES INC | Chief Clinical Dev. Officer | Stock Option (Right to Buy) | 85K | $1.43M | $16.87 | 18 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SAVA | CASSAVA SCIENCES INC | 18 Nov 2024 | 1 | $0 | 4 | Chief Clinical Dev. Officer | 20 Nov 2024, 16:39 |
| SAVA | CASSAVA SCIENCES INC | 18 Nov 2024 | 0 | $0 | 3 | Chief Clinical Dev. Officer | 20 Nov 2024, 16:37 |